Shares of Thermo Fisher Scientific Inc. TMO shed 1.04% to $528.87 Wednesday, on what proved to be an all-around great trading ...
Thermo Fisher's patent activity and acquisition strategy support growth. Find out why TMO stock is poised for continued ...
As the global energy landscape evolves towards renewable sources, electric utilities and power plant operators are ...
10h
The murder of UnitedHealthcare chief executive Brian Thompson in Manhattan on Wednesday has raised questions about security ...
This article from Thermo Scientific Data Visualization Solutions explains how Amira Software was able to solve a 60-year ...
Anixa Biosciences, Inc. ("Anixa" or the "Company") , a biotechnology company focused on the treatment and prevention of cancer, announced today that it will be participating in the iAccess Alpha ...
Consistent data across subgroups underscore the potential of PrimeC to redefine the standard of care in the treatment of ALS CAMBRIDGE, Mass., Dec. 4, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd.
Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ Detachable Dynabeads™ CD4 ...
Thermo Fisher Scientific (NYSE:TMO) has completed the repurchase of $1B (1.9M shares) of its common stock. As of Dec. 3, 2024, $3B remained available under the company’s share repurchase authorization ...
Thermo Fisher (TMO) announced that it has completed the repurchase of $1B of its common stock. As of December 3, $3B remained available under ...
The global synthetic biology market growth forecasted to transform from USD 12.33 billion in 2024 to USD 31.52 billion in 2029, driven by a CAGR of 20.6%. Rising demand for bio-based products, growing ...
Diagnostics is pleased to announce the completion of a €30 million Series D funding round, led by Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science. This investment will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback